Atlas Venture Fund Xii, L.P. Aerovate Therapeutics, Inc. (AVTE) insider trading activity
Atlas Venture Fund Xii, L.P. is > 10% Shareholder of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 2.33 Million shares of AVTE, which is worth approximately $5.7 Million. The most recent transaction as insider was on Jul 15, 2022, when has been sold 310,388 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.33M
0%
3M change
0%
12M change
Total Value Held
$5.7 Million
Atlas Venture Fund XII, L.P. Transaction History
Also insider at
AVF
Atlas Venture Fund Xii, L.P.
> 10% Shareholder
Cambridge, MA